1
|
Abstract
Excitons in Bridgman grown halide perovskite CsPbBr3 single crystals were examined using photoluminescence (PL) spectroscopy to determine the nature of the electronic states. The photoluminescence intensity was strongly temperature-dependent and depended upon the specific exciton band. At low temperatures intrinsic disorder and its related shallow below bandgap tail states determine the emission properties. Photoluminescence at low temperature revealed the presence of several strong bands at the band edge that is attributed to free or trapped/bound excitons. This PL emission results from strong electron-phonon coupling with an average phonon energy Eph of 6.5 and 27.4 meV for the emissions, comparable to that observed in other perovskites. The Huang-Rhys parameter S was calculated to be 3.81 and 1.51, indicating strong electron-phonon coupling. The interactions between electrons and phonons produce small polarons that tend to bind charge carriers and result in trapped/bound excitons. The transient photoluminescence response of each specific band was studied, and the results indicated a multiphonon recombination process. Average PL lifetimes of ∼17 ns for free excitons and ∼38 ns for trapped/bound excitons were determined. The observed edge states could be associated with native defects such as vacancies and interstitials, as well as twinning due to the cubic-to-tetragonal phase transition in CsPbBr3. Elimination of the trapping sites for binding excitons could lead to improved charge transport mobilities, carrier lifetimes, and detector properties in this system.
Collapse
Affiliation(s)
- J A Peters
- Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, United States
- Department of Chemistry, Physics, and Engineering Studies, Chicago State University, Chicago, Illinois 60628, United States
| | - Z Liu
- Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, United States
| | - O Bulgin
- Department of Chemistry, Physics, and Engineering Studies, Chicago State University, Chicago, Illinois 60628, United States
| | - Y He
- Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States
| | - V V Klepov
- Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States
| | - M C De Siena
- Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States
| | - M G Kanatzidis
- Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, United States
- Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States
| | - B W Wessels
- Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, United States
| |
Collapse
|
2
|
Dibs K, Sim AJ, Peñagaricano JA, Latifi K, Garcia GA, Peters JA, Nieder ML, Kim S, Robinson TJ. Gonadal-sparing total body irradiation with the use of helical tomotherapy for nonmalignant indications. ACTA ACUST UNITED AC 2021; 26:153-158. [PMID: 34046227 DOI: 10.5603/rpor.a2021.0006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Accepted: 12/24/2020] [Indexed: 11/25/2022]
Abstract
Background The aim was to demonstrate the feasibility and technique of gonadal sparing total body irradiation (TBI) with helical tomotherapy. Total body irradiation is a common part of the conditioning regimen prior to allogeneic stem cell transplantation. Shielding or dose-reduction to the gonads is often desired to preserve fertility, particularly in young patients undergoing transplant for non-malignant indications. Helical tomotherapy (HT) has been shown to be superior to traditional TBI delivery for organ at risk (OA R) doses and dose homogeneity. Materials and methods We present two representative cases (one male and one female) to illustrate the feasibility of this technique, each of whom received 3Gy in a single fraction prior to allogeneic stem cell transplant for benign indications. The planning target volume (PTV) included the whole body with a subtraction of OA Rs including the lungs, heart, and brain (each contracted by 1cm) as well as the gonads (testicles expanded by 5 cm and ovaries expanded by 0.5 cm). Results For the male patient we achieved a homogeneity index of 1.35 with a maximum and median planned dose to the testes of 0.53 Gy and 0.35 Gy, respectively. In-vivo dosimetry demonstrated an actual received dose of 0.48 Gy. For the female patient we achieved a homogeneity index of 1.13 with a maximum and median planned dose to the ovaries of 1.66 Gy and 0.86 Gy, respectively. Conclusion Gonadal sparing TBI is feasible and deliverable using HT in patients with non-malignant diseases requiring TBI as part of a pre-stem cell transplant conditioning regimen.
Collapse
Affiliation(s)
- Khaled Dibs
- Department of Radiation Oncology, The Ohio State University, Columbus OH, United States
| | - Austin J Sim
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| | - José A Peñagaricano
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| | - Kujtim Latifi
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| | - Genevieve A Garcia
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| | - Julia A Peters
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| | - Michael L Nieder
- Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
| | - Sungjune Kim
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| | - Timothy J Robinson
- Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States.,Department of Biostatistics and Bioinformatics, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
| |
Collapse
|
3
|
Peters JA, Heunis C, Kigozi G, Osoba T, van der Walt M. Integration of TB-HIV services at an ANC facility in Frances Baard District, Northern Cape, South Africa. Public Health Action 2015; 5:30-5. [PMID: 26400599 DOI: 10.5588/pha.14.0033] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2014] [Accepted: 01/08/2015] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Integrated tuberculosis-human immunodeficiency virus (TB-HIV) service delivery as part of maternal health services, including antenatal care (ANC), is widely recommended. This study assessed the implementation of collaborative TB-HIV service delivery at a hospital-based ANC service unit. METHODS A record review of a random sample of 308 pregnant women attending the ANC service between April 2011 and February 2012 was conducted. Data were extracted from registers and patient case notes. Outcomes included the proportion of women who underwent HIV counselling and testing (HCT), CD4 count testing, antiretroviral treatment (ART), cotrimoxazole preventive treatment (CPT), TB screening and isoniazid preventive treatment (IPT). Analysis measured variations in patient characteristics associated with service delivery. RESULTS All women underwent HCT; 80% of those who tested HIV-positive were screened for TB. Most (85.9%) of the HIV-positive women received a CD4 count. However, only 12.9% of eligible women received ART prophylaxis onsite, only 35.7% were referred for initiation of ART, only 42.3% commenced IPT and none received CPT or further investigations for TB. HIV-negative women had 2.6 higher odds (95%CI 1.3-5.3) of receiving TB screening than their HIV-positive counterparts. CONCLUSIONS Although the identification of HIV-positive women and TB suspects was adequate, implementation of other TB-HIV collaborative activities was sub-optimal.
Collapse
Affiliation(s)
- J A Peters
- Department of Public Health and Policy, University of Liverpool, Liverpool, United Kingdom ; Tuberculosis Epidemiology & Intervention Unit, Medical Research Council South Africa, Pretoria, South Africa
| | - C Heunis
- Centre for Health System Research & Development, University of the Free State, Bloemfontein, South Africa
| | - G Kigozi
- Centre for Health System Research & Development, University of the Free State, Bloemfontein, South Africa
| | - T Osoba
- Department of Public Health and Policy, University of Liverpool, Liverpool, United Kingdom
| | - M van der Walt
- Tuberculosis Epidemiology & Intervention Unit, Medical Research Council South Africa, Pretoria, South Africa
| |
Collapse
|
4
|
Greene MH, Mai PL, Loud JT, Pathak A, Peters JA, Mirabello L, McMaster ML, Rosenberg P, Stewart DR. Familial testicular germ cell tumors (FTGCT) - overview of a multidisciplinary etiologic study. Andrology 2014; 3:47-58. [PMID: 25303766 DOI: 10.1111/andr.294] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Revised: 09/08/2014] [Accepted: 09/15/2014] [Indexed: 02/06/2023]
Abstract
This Review summarizes the cumulative results of the National Cancer Institute Clinical Genetics Branch Multidisciplinary Etiologic Study of Familial Testicular Germ Cell Tumors (FTGCT). Initiated 12 years ago, this protocol enrolled 724 subjects from 147 unrelated families with either ≥2 affected men (n = 90) with TGCT or a proband with bilateral TGCT and a negative family history for this cancer (n = 57). Data were collected directly from 162 subjects evaluated at the NIH Clinical Center, and 562 subjects provided information from their home communities (Field Cohort). The primary study aims included (i) ascertaining, enrolling eligible FTGCT kindred, (ii) characterizing the clinical phenotype of multiple-case families, (iii) identifying the underlying genetic mechanism for TGCT susceptibility in families, (iv) evaluating counseling, psychosocial, and behavioral issues resulting from membership in an FTGCT family, and (v) creating an annotated biospecimen repository to permit subsequent translational research studies. Noteworthy findings include (i) documenting the epidemiologic similarities between familial and sporadic TGCT, (ii) demonstrating significantly younger age-at-diagnosis for familial vs. sporadic TGCT, (iii) absence of a dysmorphic phenotype in affected family members, (iv) shifting the focus of gene discovery from a search for rare, highly penetrant susceptibility variants to the hypothesis that multiple, more common, lower penetrance genes underlie TGCT genetic risk, (v) implicating testicular microlithiasis in FTGCT risk, and (vi) observing that aberrant methylation may contribute to FTGCT risk. A clinically based, biospecimen-intensive, multidisciplinary research strategy has provided novel, valuable insights into the etiology of FTGCT, and created a research resource which will support FTGCT clinical and laboratory studies for years to come.
Collapse
Affiliation(s)
- M H Greene
- Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Abstract
Utilizing a case report, this paper explores psychosocial aspects of suicidal intent in a woman seeking prenatal diagnosis. Using knowledge and practice of appropriate assessment, referral, and intervention procedures, the therapy team of genetic counselor and psychotherapist facilitated successful identification and management of this potentially suicidal client. The main counseling goals for the genetic counselor are to assess the situation adequately, decrease the immediate danger, and, with supervision and/or consultation, stabilize the seriously suicidal person until that individual can be triaged to mental health or medical professionals for treatment. The prevalence of suicide issues in genetic counseling contexts is unknown and reports mentioning suicidal ideation unusual in the genetic counseling literature. Is this reported case a rarity among genetic counseling referrals? Systematically collected information on the prevalence and resolution of suicidal issues in genetic counseling contexts would be helpful for those setting curricula for genetic counseling training programs, standards for professional certification exams, and policy and procedures manuals for clinical units.
Collapse
Affiliation(s)
- J A Peters
- Familial Cancer Program, Oncogenetics, 1120 W. Watkins Road, 85007, Phoenix, Arizona
| |
Collapse
|
6
|
Dickson KA, Donley JM, Hansen MW, Peters JA. Maximum sustainable speed, energetics and swimming kinematics of a tropical carangid fish, the green jack Caranx caballus. J Fish Biol 2012; 80:2494-2516. [PMID: 22650430 DOI: 10.1111/j.1095-8649.2012.03302.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Maximum sustained swimming speeds, swimming energetics and swimming kinematics were measured in the green jack Caranx caballus (Teleostei: Carangidae) using a 41 l temperature-controlled, Brett-type swimming-tunnel respirometer. In individual C. caballus [mean ±s.d. of 22·1 ± 2·2 cm fork length (L(F) ), 190 ± 61 g, n = 11] at 27·2 ± 0·7° C, mean critical speed (U(crit)) was 102·5 ± 13·7 cm s⁻¹ or 4·6 ± 0·9 L(F) s⁻¹. The maximum speed that was maintained for a 30 min period while swimming steadily using the slow, oxidative locomotor muscle (U(max,c)) was 99·4 ± 14·4 cm s⁻¹ or 4·5 ± 0·9 L(F) s⁻¹. Oxygen consumption rate (M in mg O₂ min⁻¹) increased with swimming speed and with fish mass, but mass-specific M (mg O₂ kg⁻¹ h⁻¹) as a function of relative speed (L(F) s⁻¹) did not vary significantly with fish size. Mean standard metabolic rate (R(S) ) was 170 ± 38 mg O₂ kg⁻¹ h⁻¹, and the mean ratio of M at U(max,c) to R(S) , an estimate of factorial aerobic scope, was 3·6 ± 1·0. The optimal speed (U(opt) ), at which the gross cost of transport was a minimum of 2·14 J kg⁻¹ m⁻¹, was 3·8 L(F) s⁻¹. In a subset of the fish studied (19·7-22·7 cm L(F) , 106-164 g, n = 5), the swimming kinematic variables of tailbeat frequency, yaw and stride length all increased significantly with swimming speed but not fish size, whereas tailbeat amplitude varied significantly with speed, fish mass and L(F) . The mean propulsive wavelength was 86·7 ± 5·6 %L(F) or 73·7 ± 5·2 %L(T) . Mean ±s.d. yaw and tailbeat amplitude values, calculated from lateral displacement of each intervertebral joint during a complete tailbeat cycle in three C. caballus (19·7, 21·6 and 22·7 cm L(F) ; 23·4, 25·3 and 26·4 cm L(T) ), were 4·6 ± 0·1 and 17·1 ± 2·2 %L(T) , respectively. Overall, the sustained swimming performance, energetics, kinematics, lateral displacement and intervertebral bending angles measured in C. caballus were similar to those of other active ectothermic fishes that have been studied, and C. caballus was more similar to the chub mackerel Scomber japonicus than to the kawakawa tuna Euthynnus affinis.
Collapse
Affiliation(s)
- K A Dickson
- Department of Biological Science, California State University Fullerton, Fullerton, CA 92834, USA.
| | | | | | | |
Collapse
|
7
|
|
8
|
|
9
|
Alexander SPH, Mathie A, Peters JA. NUCLEAR RECEPTORS. Br J Pharmacol 2011. [DOI: 10.1111/j.1476-5381.2011.01649_6.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
10
|
|
11
|
|
12
|
|
13
|
|
14
|
Abstract
We have demonstrated the first bipolar magnetic junction transistor using a dilute magnetic semiconductor. For an InMnAs p-n-p transistor magnetoamplification is observed at room temperature. The observed magnetoamplification is attributed to the magnetoresistance of the magnetic semiconductor InMnAs heterojunction. The magnetic field dependence of the transistor characteristics confirm that the magnetoamplification results from the junction magnetoresistance. To describe the experimentally observed transistor characteristics, we propose a modified Ebers-Moll model that includes a series magnetoresistance attributed to spin-selective conduction. The capability of magnetic field control of the amplification in an all-semiconductor transistor at room temperature potentially enables the creation of new computer logic architecture where the spin of the carriers is utilized.
Collapse
Affiliation(s)
- N Rangaraju
- Materials Research Center, Northwestern University, Evanston, Illinois, USA
| | | | | |
Collapse
|
15
|
|
16
|
|
17
|
|
18
|
Alexander SPH, Mathie A, Peters JA. A Key to the Tables. Br J Pharmacol 2008. [DOI: 10.1038/sj.bjp.0707752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
19
|
Alexander SPH, Mathie A, Peters JA. Buyer's Guide. Br J Pharmacol 2008. [DOI: 10.1038/sj.bjp.0707760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
20
|
Lambert JJ, Peters JA, Sturgess NC, Hales TG. Steroid modulation of the GABAA receptor complex: electrophysiological studies. Ciba Found Symp 2007; 153:56-71; discussion 71-82. [PMID: 1963400 DOI: 10.1002/9780470513989.ch4] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The effect of some endogenous and synthetic steroids on the operation of inhibitory and excitatory amino acid neurotransmitter receptors was examined. Anaesthetic pregnane steroids (e.g. alphaxalone, 5 alpha-pregnan-3 alpha-ol-20-one, 5 alpha-pregnane-3 alpha,21-diol-20-one) potentiated GABAA receptor-mediated whole-cell currents recorded from bovine chromaffin cells. The threshold concentration for enhancement was 10-30 nM. Potentiation was stereoselective and was mediated by a steroid-induced prolongation of the burst duration of the GABA-activated channel. Additionally, the pregnane steroids directly activated the GABAA receptor. Both the potentiation and activation appear to be mediated through a site(s) distinct from the well-known barbiturate and benzodiazepine allosteric sites of the GABAA receptor. Intracellularly applied alphaxalone and 5 beta-pregnan-3 alpha-ol-20-one had no discernible effects on the GABAA receptor, suggesting that the steroid binding site can only be accessed extracellularly. Unlike behaviourally depressant barbiturates, which modulate GABAA receptor function in a manner similar to that of the pregnane steroids, alphaxalone and 5 beta-pregnan-3 alpha-ol-20-one show striking pharmacological selectivity. Voltage-clamp recordings from rat central neurons in culture indicate that pentobarbitone exerts its potentiating and GABA-mimetic effects over a range of concentrations which also depress currents mediated by glutamate receptor subtypes. In contrast, alphaxalone and several endogenous steroids greatly enhance responses to GABA, but have no direct effect on glutamate receptors. Such pharmacological selectivity, coupled with appropriate stereoselectivity of action, suggests that the GABAA receptor mediates some of the behavioural effects of synthetic and endogenous pregnane steroids.
Collapse
Affiliation(s)
- J J Lambert
- Department of Pharmacology & Clinical Pharmacology, Ninewells Hospital & Medical School, Dundee University, UK
| | | | | | | |
Collapse
|
21
|
Peters JA, Carland JE, Cooper MA, Livesey MR, Deeb TZ, Hales TG, Lambert JJ. Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptors. Biochem Soc Trans 2007; 34:882-6. [PMID: 17052220 DOI: 10.1042/bst0340882] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Nicotinic ACh (acetylcholine) and 5-HT3 (5-hydroxytryptamine type-3) receptors are cation-selective ion channels of the Cys-loop transmitter-gated ion channel superfamily. Numerous lines of evidence indicate that the channel lining domain of such receptors is formed by the alpha-helical M2 domain (second transmembrane domain) contributed by each of five subunits present within the receptor complex. Specific amino acid residues within the M2 domain have accordingly been demonstrated to influence both single-channel conductance (gamma) and ion selectivity. However, it is now clear from work performed on the homomeric 5-HT3A receptor, heteromeric 5-HT3A/5-HT3B receptor and 5-HT3A/5-HT3B receptor subunit chimaeric constructs that an additional major determinant of gamma resides within a cytoplasmic domain of the receptor termed the MA-stretch (membrane-associated stretch). The MA-stretch, within the M3-M4 loop, is not traditionally thought to be implicated in ion permeation and selection. Here, we describe how such observations extend to a representative neuronal nicotinic ACh receptor composed of alpha4 and beta2 subunits and, by inference, probably other members of the Cys-loop family. In addition, we will attempt to interpret our results within the context of a recently developed atomic scale model of the nicotinic ACh receptor of Torpedo marmorata (marbled electric ray).
Collapse
Affiliation(s)
- J A Peters
- Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, The University of Dundee, Dundee DD1 9SY, UK.
| | | | | | | | | | | | | |
Collapse
|
22
|
Affiliation(s)
- S P H Alexander
- School of Biomedical Sciences and Institute of Neuroscience, University of Nottingham Medical School, UK.
| | | | | |
Collapse
|
23
|
Alexander SPH, Mathie A, Peters JA. Phosphodiesterases, 3′,5′-cyclic nucleotide (E.C.3.1.4.17). Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
24
|
Alexander SPH, Mathie A, Peters JA. Anaphylatoxin and chemotactic peptide. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
25
|
Alexander SPH, Mathie A, Peters JA. Neuropeptides B and W. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
26
|
Alexander SPH, Mathie A, Peters JA. Glutamate, metabotropic. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
27
|
|
28
|
Alexander SPH, Mathie A, Peters JA. Urotensin-II. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
29
|
Alexander SPH, Mathie A, Peters JA. Angiotensin. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
30
|
Alexander SPH, Mathie A, Peters JA. Lipoxygenases (E.C. 1.13.11.−). Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
31
|
Alexander SPH, Mathie A, Peters JA. P2Y. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
32
|
Alexander SPH, Mathie A, Peters JA. 5-Hydroxytryptamine3. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
33
|
Alexander SPH, Mathie A, Peters JA. Trace amine-associated. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
34
|
|
35
|
|
36
|
Alexander SPH, Mathie A, Peters JA. Toll-like family. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
37
|
Alexander SPH, Mathie A, Peters JA. Leukotriene. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
38
|
Alexander SPH, Mathie A, Peters JA. Resolvin. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
39
|
|
40
|
Alexander SPH, Mathie A, Peters JA. Bombesin. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
41
|
Alexander SPH, Mathie A, Peters JA. GDNF family. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
42
|
Alexander SPH, Mathie A, Peters JA. Platelet-activating factor. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
43
|
Alexander SPH, Mathie A, Peters JA. Somatostatin. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
44
|
Alexander SPH, Mathie A, Peters JA. Steroid hormone. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
45
|
Alexander SPH, Mathie A, Peters JA. Phosphatidylcholine-specific phospholipase D (E.C. 3.1.4.4). Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
46
|
Alexander SPH, Mathie A, Peters JA. Glutamate (ionotropic). Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
47
|
Alexander SPH, Mathie A, Peters JA. GABAB. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
48
|
Alexander SPH, Mathie A, Peters JA. GABA. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
49
|
Alexander SPH, Mathie A, Peters JA. Decarboxylases (E.C. 4.1.1.−). Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
50
|
Alexander SPH, Mathie A, Peters JA. Natriuretic peptide. Br J Pharmacol 2006. [DOI: 10.1038/sj.bjp.0706478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|